|
Dec 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,572,131
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Dec 2024
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
194,561,357
|
33.50%
|
39,060,000
|
20.08%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,572,131
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Sep 2024
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
194,561,357
|
33.50%
|
46,760,000
|
24.03%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Jun 2024
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
46,760,000
|
23.81%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2024
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Mar 2024
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
46,760,000
|
23.81%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Dec 2023
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
40,795,862
|
20.77%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Sep 2023
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
42,795,862
|
21.79%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Jun 2023
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
39,795,862
|
20.27%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2023
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Mar 2023
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
39,795,862
|
20.27%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
Dec 2022
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
31,195,862
|
15.89%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
Sep 2022
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
27,465,862
|
13.99%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
Jun 2022
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
27,465,862
|
13.99%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2022
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,750,000
|
22.42%
|
0
|
0.00%
|
|
Mar 2022
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
27,465,862
|
13.99%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
6,856,000
|
40.99%
|
0
|
0.00%
|
|
Dec 2021
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
51,450,365
|
26.20%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
6,970,000
|
41.67%
|
0
|
0.00%
|
|
Sep 2021
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
51,356,365
|
26.15%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
110,000
|
0.66%
|
0
|
0.00%
|
|
Jun 2021
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
50,071,862
|
25.50%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2021
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,710,000
|
22.18%
|
0
|
0.00%
|
|
Mar 2021
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
50,071,862
|
25.50%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
10,000
|
0.06%
|
0
|
0.00%
|
|
Dec 2020
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
12,576,000
|
6.40%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
Sep 2020
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
9,560,000
|
4.87%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
Jun 2020
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2020
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
Mar 2020
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
Dec 2019
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
Sep 2019
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.51%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
Jun 2019
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2019
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,726,716
|
2.85%
|
3,100,000
|
18.53%
|
0
|
0.00%
|
|
Mar 2019
|
Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2018
|
Rpr Sons Advisors Private, Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2018
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Sep 2018
|
Rpr Sons Advisors Private Limited, Mrs.P Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2018
|
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Jun 2018
|
Rpr Sons Advisors Private Limited, Mrs.P Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2018
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,426,716
|
2.80%
|
0
|
0.00%
|
0
|
0.00%
|
|
Mar 2018
|
Rpr Sons Advisors Private Limited Mrs P Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2017
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)
|
16,426,716
|
2.80%
|
0
|
0.00%
|
0
|
0.00%
|
|
Dec 2017
|
Rpr Sons Advisors Private Limited Mrs P Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2017
|
Rpr Sons Advisors Private Limited
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2017
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Jun 2017
|
Rpr Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2017
|
Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd (Jointly Holding)
|
16,726,716
|
2.85%
|
0
|
0.00%
|
0
|
0.00%
|
|
Mar 2017
|
Rpr Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani (Jointly Holding)
|
196,376,250
|
33.52%
|
0
|
0.00%
|
0
|
0.00%
|